National Lung Cancer Audit annual report 2017
This is the 13th annual report on the clinical component (process of care) of the National Lung Cancer Audit. It contains national and named team results on the quality of lung cancer care for patients diagnosed between 1 January and 31 December 2016 and covers many processes of care across the entire patient pathway.
Targeted audiences who will benefit from reading the findings of this report include NHS staff in lung cancer multidisciplinary teams; hospital managers and chief executives; commissioners; lung cancer researchers; lung cancer patients their families and their carers who may use the findings to inform their care decisions.
The NCLA is delivered in partnership with a number of key stakeholders who have contributed to this report. The University of Nottingham provides the analysis for England, Wales, and Guernsey. Clinical Leadership is provided by lung cancer experts recruited through the Care Quality Improvement Department at the RCP. The NLCA executive group is constituted by the Society for Cardiothoracic Surgery, the Roy Castle Lung Cancer Foundation (representing for lung cancer patients), Wales Cancer Network Lung Cancer Group, the National Lung Cancer Forum for Nurses and the British Thoracic Oncology Group.